ATE112309T1 - Schutz zytolytischer aktivität von nk-zellen in peripheren blut-mononuklearzellen. - Google Patents

Schutz zytolytischer aktivität von nk-zellen in peripheren blut-mononuklearzellen.

Info

Publication number: ATE112309T1
Authority: AT; Austria
Prior art keywords: cells; peripheral blood; blood mononuclear; protection; cytolytic activity
Prior art date: 1989-07-21

Application number

AT90911369T

Other languages

English (en)

Inventor

Kam Hung Leung

Original Assignee

Terumo Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-07-21

Filing date

1990-07-17

Publication date

1994-10-15

1990-07-17 Application filed by Terumo Corp filed Critical Terumo Corp

1994-10-15 Application granted granted Critical

1994-10-15 Publication of ATE112309T1 publication Critical patent/ATE112309T1/de

Links

210000004027 cell Anatomy 0.000 title 1
230000001461 cytolytic effect Effects 0.000 title 1
210000005087 mononuclear cell Anatomy 0.000 title 1
210000005259 peripheral blood Anatomy 0.000 title 1
239000011886 peripheral blood Substances 0.000 title 1
KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 2
230000031942 natural killer cell mediated cytotoxicity Effects 0.000 abstract 2
VPSSPAXIFBTOHY-LURJTMIESA-N (2s)-2-amino-4-methylpentan-1-ol Chemical compound CC(C)C[C@H](N)CO VPSSPAXIFBTOHY-LURJTMIESA-N 0.000 abstract 1
108010016626 Dipeptides Proteins 0.000 abstract 1
108010002350 Interleukin-2 Proteins 0.000 abstract 1
STVVMTBJNDTZBF-VIFPVBQESA-N L-phenylalaninol Chemical compound OC[C@@H](N)CC1=CC=CC=C1 STVVMTBJNDTZBF-VIFPVBQESA-N 0.000 abstract 1
150000001408 amides Chemical class 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
238000011534 incubation Methods 0.000 abstract 1
210000003819 peripheral blood mononuclear cell Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4613—Natural-killer cells [NK or NK-T]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT90911369T 1989-07-21 1990-07-17 Schutz zytolytischer aktivität von nk-zellen in peripheren blut-mononuklearzellen. ATE112309T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/383,222 US5198334A (en)	1989-07-21	1989-07-21	Protection of natural killer cell cytolytic activity in peripheral blood mononuclear cells

Publications (1)

Publication Number	Publication Date
ATE112309T1 true ATE112309T1 (de)	1994-10-15

Family

ID=23512227

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90911369T ATE112309T1 (de)	1989-07-21	1990-07-17	Schutz zytolytischer aktivität von nk-zellen in peripheren blut-mononuklearzellen.

Country Status (10)

Country	Link
US (1)	US5198334A (de)
EP (1)	EP0483237B1 (de)
JP (1)	JPH05504884A (de)
AT (1)	ATE112309T1 (de)
AU (1)	AU6049390A (de)
CA (1)	CA2063788A1 (de)
DE (1)	DE69012999T2 (de)
DK (1)	DK0483237T3 (de)
ES (1)	ES2061057T3 (de)
WO (1)	WO1991001370A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4308350B2 (ja) *	1998-11-27	2009-08-05	小林製薬株式会社	シイタケ菌糸体抽出物を含有するｌａｋ活性スクリーニング物質およびそれを用いたｌａｋ活性スクリーニング法
US6153113A (en)	1999-02-22	2000-11-28	Cobe Laboratories, Inc.	Method for using ligands in particle separation
US6354986B1 (en)	2000-02-16	2002-03-12	Gambro, Inc.	Reverse-flow chamber purging during centrifugal separation
AU2001262697A1 (en) *	2000-06-06	2001-12-17	Kirin Beer Kabushiki Kaisha	Method of amplifying natural killer t cells
CN102781958B (zh) *	2009-12-05	2017-07-11	马尔瓦有限责任公司	基于顶复虫Ferlin、Ferlin样蛋白和其它含有C2结构域的蛋白的疟疾疫苗

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4752602A (en) *	1985-09-09	1988-06-21	Board Of Regents, The University Of Texas System	Dipeptide alkyl esters and their uses
US4849329A (en) *	1986-05-30	1989-07-18	E. I. Du Pont De Nemours And Company	Process for preparing lymphokine activated killer cells

1989
- 1989-07-21 US US07/383,222 patent/US5198334A/en not_active Expired - Lifetime
1990
- 1990-07-17 DE DE69012999T patent/DE69012999T2/de not_active Expired - Fee Related
- 1990-07-17 AT AT90911369T patent/ATE112309T1/de not_active IP Right Cessation
- 1990-07-17 EP EP90911369A patent/EP0483237B1/de not_active Expired - Lifetime
- 1990-07-17 WO PCT/US1990/003902 patent/WO1991001370A1/en active IP Right Grant
- 1990-07-17 ES ES90911369T patent/ES2061057T3/es not_active Expired - Lifetime
- 1990-07-17 CA CA002063788A patent/CA2063788A1/en not_active Abandoned
- 1990-07-17 AU AU60493/90A patent/AU6049390A/en not_active Abandoned
- 1990-07-17 DK DK90911369.8T patent/DK0483237T3/da active
- 1990-07-17 JP JP2510589A patent/JPH05504884A/ja active Pending

Also Published As

Publication number	Publication date
US5198334A (en)	1993-03-30
EP0483237B1 (de)	1994-09-28
DE69012999D1 (de)	1994-11-03
DK0483237T3 (da)	1995-04-10
DE69012999T2 (de)	1995-01-26
JPH05504884A (ja)	1993-07-29
ES2061057T3 (es)	1994-12-01
WO1991001370A1 (en)	1991-02-07
EP0483237A1 (de)	1992-05-06
AU6049390A (en)	1991-02-22
CA2063788A1 (en)	1991-01-22

Similar Documents

Publication	Publication Date	Title
ATE63748T1 (de)	1991-06-15	Enzymwiderstandsfaehige immunomodulatorische peptide.
ATE193418T1 (de)	2000-06-15	Dekontaminierung von plättchen mit 8- methoxypsoralen
ES2186714T3 (es)	2003-05-16	Uso de sustipo simple alpha 8 en la preparacion de medicamentos para el tratamiento de infecciones virales del higado.
FR2470794A1 (fr)	1981-06-12	Nouvelles microparticules, leur preparation et leurs applications en biologie, notamment a la culture de cellules diploides humaines
IT1232827B (it)	1992-03-05	Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
EP0879056A4 (de)	1999-01-13	Modalation der th1/th2 cytokinexpression durch ribavirin-m(3) und ribavirin-(m3) analogen in aktivierten t-lymphozyten
DE69430059D1 (de)	2002-04-11	Freisetzung und Mobilisierung hämatopoietischer Zellen
DE69409518D1 (de)	1998-05-14	Polyarminearme nähr- und/oder heilmittelzusammensetzung und therapeutische verwendung derselben
ATE112309T1 (de)	1994-10-15	Schutz zytolytischer aktivität von nk-zellen in peripheren blut-mononuklearzellen.
FI893681A (fi)	1990-02-05	N-2,3-butadienyltri- och tetra-aminoalkanderivat.
ES2058479T3 (es)	1994-11-01	Compuestos peptidicos.
DE69725882D1 (de)	2003-12-04	Adenovirus e4 proteine für induktion von zelltod
DE69902520D1 (de)	2002-09-19	Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
CA1265818C (en)	1990-02-13	NON-AROMATIC FLUOROALLYLAMINES MAO INHIBITORS
ATE123807T1 (de)	1995-06-15	Verstärkte aktivierung von lak-zellen durch behandlung menschlicher peripherer mononuklearer blutzellen mit aminosäuren.
MY131599A (en)	2007-08-30	Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
ATE62789T1 (de)	1991-05-15	Mittel zur bekaempfung von phytopathogenen mikroben.
IT1203657B (it)	1989-02-15	Impiego in terapia di n-(dietilamminoetil)-2-metossi-5-metilsolfonil-benzammide e medicamento che la contiene
AU6044090A (en)	1991-02-22	Preparation of human adherent lymphokine-activated killer (a-lak) cells
DK222988A (da)	1988-10-24	Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
FI941451A0 (fi)	1994-03-29	Entsymaattisesti valmistettu dimeerinen IL-2 ja sen valmistuksessa käytettävä, hermoista johdettu transglutaminaasi
ES2114170T3 (es)	1998-05-16	Peptidos con actividad organo-protectora, su procedimiento de preparacion y su utilizacion en la terapia.
GR3003773T3 (de)	1993-03-16
RU94017351A (ru)	1996-08-10	Средство для профилактики и лечения лучевых поражений
CO4480761A1 (es)	1997-07-09	Metodo para movilizar celulas tronco hematopoyeticas

Legal Events

Date	Code	Title	Description
1995-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties